Proteome Sciences PLC (PRM) — Cash Flow-to-Debt Ratio
Proteome Sciences PLC (PRM) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of GBX851.00K could theoretically repay 0% of its total liabilities (GBX17.79 Million) in one year. Check PRM cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Proteome Sciences PLC Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Proteome Sciences PLC across 31 annual periods. Also explore PRM total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Proteome Sciences PLC (1994–2025)
Year-by-year debt coverage analysis for Proteome Sciences PLC. For market capitalisation and broader financial context, see market cap of Proteome Sciences PLC.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | GBX-46.00K | GBX17.79 Million | ▲ +95.1% |
| 2024 | -0.05x | GBX-826.00K | GBX15.72 Million | ▼ -58.6% |
| 2023 | -0.03x | GBX-481.00K | GBX14.52 Million | ▼ -2235443.5% |
| 2022 | 0.00x | GBX2.14 Million | GBX1.44 Trillion | ▲ +145.5% |
| 2021 | 0.00x | GBX793.00K | GBX1.31 Trillion | ▼ -51.1% |
| 2020 | 0.00x | GBX1.58 Million | GBX1.28 Trillion | ▲ +100.0% |
| 2019 | -0.02x | GBX-21.45 Billion | GBX1.07 Trillion | ▼ -44.5% |
| 2018 | -0.01x | GBX-14.78 Billion | GBX1.07 Trillion | ▼ -126.6% |
| 2017 | 0.05x | GBX55.47 Billion | GBX1.07 Trillion | ▲ +119.5% |
| 2016 | -0.27x | GBX-31.70 Billion | GBX119.08 Billion | ▼ -701.7% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.05 Trillion | ▲ +1012.0% |
| 2014 | 0.00x | GBX-6.27 Billion | GBX1.29 Trillion | ▲ +46.3% |
| 2013 | -0.01x | GBX-11.55 Billion | GBX1.28 Trillion | ▲ +97.9% |
| 2012 | -0.43x | GBX-3.35 Million | GBX7.72 Million | ▲ +36.0% |
| 2011 | -0.68x | GBX-5.17 Million | GBX7.61 Million | ▼ -242.1% |
| 2010 | 0.48x | GBX4.00 Million | GBX8.38 Million | ▲ +348.2% |
| 2009 | -0.19x | GBX-2.97 Million | GBX15.44 Million | ▲ +43.6% |
| 2008 | -0.34x | GBX-4.12 Million | GBX12.07 Million | ▲ +26.6% |
| 2007 | -0.47x | GBX-4.09 Million | GBX8.80 Million | ▲ +50.9% |
| 2006 | -0.95x | GBX-3.61 Million | GBX3.81 Million | ▲ +65.8% |
| 2005 | -2.77x | GBX-4.77 Million | GBX1.72 Million | ▼ -12.9% |
| 2004 | -2.45x | GBX-3.77 Million | GBX1.54 Million | ▼ -29.8% |
| 2003 | -1.89x | GBX-4.88 Million | GBX2.58 Million | ▼ -14.4% |
| 2002 | -1.65x | GBX-3.27 Million | GBX1.98 Million | ▼ -31.5% |
| 2001 | -1.26x | GBX-1.55 Million | GBX1.24 Million | ▼ -73.3% |
| 2000 | -0.72x | GBX-1.14 Million | GBX1.57 Million | ▲ +59.7% |
| 1999 | -1.80x | GBX-1.25 Million | GBX697.00K | ▼ -0.5% |
| 1998 | -1.79x | GBX-1.54 Million | GBX862.00K | ▲ +23.3% |
| 1997 | -2.33x | GBX-1.29 Million | GBX551.00K | ▲ +61.1% |
| 1996 | -6.01x | GBX-1.71 Million | GBX285.00K | ▼ -410.9% |
| 1994 | -1.18x | GBX-809.00K | GBX688.00K | — |